Ohtani; Mitsuaki

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ohtani; Mitsuaki.The latest application filed is for "benzoimidazole derivatives and glycogen synthase kinase-3 beta inhibitors containing the same".

Company Profile

0.21.4

Ohtani; Mitsuaki - Kanagawa JP
Ohtani; Mitsuaki - Nara JP
Ohtani; Mitsuaki - Osaka JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Benzoimidazole Derivatives and Glycogen Synthase Kinase-3 Beta Inhibitors Containing the Same App 20110190351 - Ohtani; Mitsuaki ; et al.	2011-08-04
Para-terphenyl compounds Grant 7,220,783 - Kawada , et al. May 22, 2	2007-05-22
P-terphenyl compounds Grant 7,101,915 - Kawada , et al. September 5, 2	2006-09-05
Para-terphenyl compounds Grant 7,074,836 - Kawada , et al. July 11, 2	2006-07-11
Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same Grant 6,919,375 - Wantanabe , et al. July 19, 2	2005-07-19
Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same Grant 6,881,727 - Watanabe , et al. April 19, 2	2005-04-19
Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same Grant 6,838,483 - Wantanabe , et al. January 4, 2	2005-01-04
Pyrrolotriazine derivatives having spla2-inhibitory activities Grant 6,787,545 - Ohtani , et al. September 7, 2	2004-09-07
Novel para-terphenyl compounds App 20040127495 - Kawada, Kenji ; et al.	2004-07-01
Tricyclic compounds having sPLA2-inhibitory activities Grant 6,703,385 - Ohtani , et al. March 9, 2	2004-03-09
Tricyclic compounds having sPLA2-inhibitory activities Grant 6,673,781 - Ohtani , et al. January 6, 2	2004-01-06
Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same App 20030225043 - Watanabe, Fumihiko ; et al.	2003-12-04
Indolizine SPLA2inhibitors Grant 6,645,976 - Dillard , et al. November 11, 2	2003-11-11
Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same App 20030139379 - Watanabe, Fumihiko ; et al.	2003-07-24
Pyrrolo[1,2-b] pyridazine derivatives having sPLA2 inhibitory effect Grant 6,472,389 - Ohtani , et al. October 29, 2	2002-10-29
Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same Grant 6,235,768 - Wantanabe , et al. May 22, 2	2001-05-22
Bicyclic amino derivatives and PGD2 antagonist containing the same Grant 6,172,113 - Ohtani , et al. January 9, 2	2001-01-09
Pyrrolidine derivatives having phospholipase A.sub.2 inhibitory activity Grant 6,147,100 - Seno , et al. November 14, 2	2000-11-14
Oxazolinone derivatives having cytosolic phospholipase A.sub.2 inhibitory activity Grant 5,817,826 - Ohtani , et al. October 6, 1	1998-10-06
Preparation of optically active 1,4-bridged-cyclohexane carboxylic acid derivatives Grant 5,763,647 - Ohtani , et al. June 9, 1	1998-06-09
Carboxylate derivatives exhibiting phospholipase A2 inhibitory activity Grant 5,534,533 - Ohtani , et al. July 9, 1	1996-07-09
Aromatic-sulfonamide-type hydroxamic acid derivative Grant 5,534,654 - Ohtani , et al. July 9, 1	1996-07-09
Certain optically active mono esters of dicarboxylic acids Grant 5,047,574 - Ohtani , et al. September 10, 1	1991-09-10
Bicyclic sulfonamide derivatives Grant 4,861,913 - Narisada , et al. August 29, 1	1989-08-29
Epimerization of malonic acid esters Grant 4,504,658 - Narisada , et al. March 12, 1	1985-03-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.